Status:
COMPLETED
Effects of Capsimax on Appetite, Energy Intake and Blood Pressure
Lead Sponsor:
Laval University
Collaborating Sponsors:
OmniActive Health Technologies
Conditions:
Obesity
Body Weight
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
Obesity is an ongoing major public health problem in most countries of the world for which the agrifood industry still remains criticized because of the abundant offer of high sugar-lipid-energy dense...
Eligibility Criteria
Inclusion
- Premenopausal women
- Between 18 and 50 years
- Healthy
- Non-smoker
- BMI between 25 and 35 kg/m2
- Weight stability
Exclusion
- Pregnant or menopausal woman
- History of losing and gaining weight (yo-yo)
- Taking medication for diabetes, hypertension, depression, or hypothyroid
- Taking a supplement for weight loss
- Vegetarian, vegan, intolerant to gluten or pepper (investigational product), and severe allergy to peanuts or nuts
- Suffers from Irritable Bowel Syndrome or gastro-oesophageal reflux
- Suffers from stomach ulcers or inflammation
- Other serious conditions such as cardiovascular, renal, liver, and lung diseases
- History of drug abuse and current alcohol abuse
- Use of any medication (including over-the-counter medications and herbal remedies) such as grapefruit juice, piperine, NSAIDs, etc.
Key Trial Info
Start Date :
January 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2019
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04874701
Start Date
January 7 2018
End Date
July 2 2019
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PEPS-Université Laval
Québec, Canada, G1V0A6